Serum Markers of B-cell Activation in Pregnancy During Late Gestation, Delivery, and the Postpartum Period
- PMID: 30624814
- PMCID: PMC6590212
- DOI: 10.1111/aji.13090
Serum Markers of B-cell Activation in Pregnancy During Late Gestation, Delivery, and the Postpartum Period
Abstract
Problem: B cells are vital for the normal evolution of pregnancy due to their humoral and possible regulatory activities. Our group and others have documented that circulating B-cell subsets undergo changes from normal late pregnancy to the postpartum period. However, the underlying mechanisms are poorly understood. Therefore, this study examined the degree of B-cell activation in normal pregnancy by analyzing the levels of serum markers in healthy pregnant women during the third trimester of pregnancy, the day of delivery, and the postpartum period.
Method of study: A prospective study including pregnant and non-pregnant women attending routine care was undertaken at a hospital clinic. Sociodemographic and clinical data were collected, along with peripheral blood samples. The serum levels of soluble CD23 (sCD23), B-cell-activating factor (BAFF), kappa (κ) and lambda (λ) free light chains (FLC), IgA, IgG, and IgM were quantified.
Results: Our study included 43 third trimester pregnant and 35 non-pregnant women. In the pregnant women, the median levels of sCD23, BAFF, IgG, and κ FLC were significantly higher during the postpartum period than during the third trimester of pregnancy. Compared to the non-pregnant women, the third trimester pregnant women had higher median BAFF levels and lower sCD23, IgA, IgG, and FLC levels.
Conclusion: Changes in serum markers of B-cell kinetics that occur during pregnancy often persist into the postpartum period and affect the secretion of immunoglobulins from different classes. Further studies are needed to clarify the biological significance of our observations.
Keywords: B lymphocytes; B-cell-activating factor; biomarkers; female; free light chains; immunoglobulins; pregnancy; soluble CD23.
© 2019 The Authors. American Journal of Reproductive Immunology Published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures
Similar articles
-
Maternal Serum B-Cell Activating Factor Levels: Candidate Early Biomarker for Hypertensive Disorders of Pregnancy.Hypertension. 2017 Nov;70(5):1007-1013. doi: 10.1161/HYPERTENSIONAHA.117.09775. Epub 2017 Sep 18. Hypertension. 2017. PMID: 28923901 Clinical Trial.
-
Characterization of B cells in healthy pregnant women from late pregnancy to post-partum: a prospective observational study.BMC Pregnancy Childbirth. 2016 Jun 6;16(1):139. doi: 10.1186/s12884-016-0927-7. BMC Pregnancy Childbirth. 2016. PMID: 27267973 Free PMC article. Clinical Trial.
-
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu.J Clin Pathol. 2018 Jul;71(7):620-625. doi: 10.1136/jclinpath-2017-204656. Epub 2018 Jan 31. J Clin Pathol. 2018. PMID: 29447111
-
Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity.J Assist Reprod Genet. 2015 Dec;32(12):1765-72. doi: 10.1007/s10815-015-0588-x. Epub 2015 Oct 14. J Assist Reprod Genet. 2015. PMID: 26466939 Free PMC article.
-
[Clinical implications of occurrence of antithyroid antibodies in pregnant women and in the postpartum period].Przegl Lek. 2004;61(8):864-7. Przegl Lek. 2004. PMID: 15789919 Review. Polish.
Cited by 1 article
-
Graves' Disease and the Post-partum Period: An Intriguing Relationship.Front Endocrinol (Lausanne). 2019 Dec 10;10:853. doi: 10.3389/fendo.2019.00853. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31920967 Free PMC article. Review.
References
-
- Jensen F, Wallukat G, Herse F, et al. CD19+CD5+ cells as indicators of preeclampsia. Hypertension. 2012;59:861‐868. - PubMed
-
- Muzzio D, Zenclussen AC, Jensen F. The role of B cells in pregnancy: the good and the bad. Am J Reprod Immunol. 2013;69:408‐412. - PubMed
-
- Saccone G, Berghella V, Maruotti GM, et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol. 2017;216(525):525.e1‐525.e12. - PubMed
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
